The affordability of newly approved anticancer agents is a challenge to many national health services and reimbursement systems. Therefore, we have developed an approach based upon the adoption of a novel model of price setting and herein provide examples of how it might be implemented. This model is intended to alter the balance between social and economic entrepreneurship.
CITATION STYLE
Uyl-De Groot, C. A., & Löwenberg, B. (2018). Sustainability and affordability of cancer drugs: A novel pricing model. Nature Reviews Clinical Oncology, 15(7), 405–406. https://doi.org/10.1038/s41571-018-0027-x
Mendeley helps you to discover research relevant for your work.